Tnni3k Is Cardioprotective in Viral Myocarditis

Area of Science:

• Cardiovascular Research
• Immunology
• Genetics

Background:

• Viral myocarditis severity varies due to host genetics.
• The viral myocarditis susceptibility locus (Vms1) was previously mapped using resistant and sensitive mouse strains.
• Specific genes influencing disease course remain largely unidentified.

Purpose of the Study:

• To investigate the role of the gene Tnni3k, located within the Vms1 locus, in modulating coxsackievirus CVB3-induced myocarditis.
• To determine if Tnni3k kinase activity is essential for its protective function.

Main Methods:

• Utilized Tnni3k knockout mice and a kinase-dead Tnni3k mutant mouse line.
• Inoculated mice with coxsackievirus CVB3.
• Assessed cardiac inflammation and macrophage infiltration in the heart.

Main Results:

• Tnni3k knockout mice exhibited significantly higher cardiac inflammation and macrophage infiltration compared to wild-type controls.
• Mice with a kinase-dead Tnni3k mutation showed similar elevated inflammation levels.
• Long-term cardiac damage was comparable between genotypes, indicating a role in the acute phase.

Conclusions:

• Tnni3k acts as a protective factor in the acute inflammatory response to CVB3 infection in the heart.
• Tnni3k's kinase activity is crucial for its role in modulating cardiac inflammation.
• Identifying Tnni3k provides a potential target for therapeutic strategies against viral myocarditis.